Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Stool-Based DNA Testing Leads to Timely Colonoscopy

By LabMedica International staff writers
Posted on 15 Oct 2025

Colorectal cancer (CRC) remains a leading cause of cancer deaths in the US, yet many patients delay colonoscopy due to hesitancy and long wait times. More...

Long follow-up intervals after stool-based testing could further exacerbate health disparities in rural patients who already face significant barriers to health care. Now, a new observational study has shown that stool-based DNA testing can provide timely follow-up for both rural and urban patients and thus help increase equitable CRC screening.

The observational case–control analysis by researchers from the University of North Dakota (Grand Forks, ND, USA) included 1316 patients 18 years or older who had a positive DNA-based stool test and subsequently underwent diagnostic colonoscopy between January 2018 and December 2023. Participants were categorized as rural or nonrural using Rural-Urban Commuting Area codes, and the primary outcome was days from a positive stool test to diagnostic colonoscopy.

Of the 1,316 patients included, 668 (50.8% were classified as rural; the median time to diagnostic colonoscopy was similar between groups — 35 days for rural patients versus 37 days for nonrural patients (P=.6). Rural patients were significantly more likely to have their colonoscopy performed at an external facility (25% vs 3.1%; P<.001), despite comparable timeliness. In their research published in The American Surgeon, the authors note limitations, including reliance on recorded data and that the analysis focused only on patients who completed both stool testing and colonoscopy.

The investigators concluded that the findings support stool-based DNA testing as a tool to increase screening access and deliver timely diagnostic follow-up across geographic settings. At the study institution, the results informed plans to use stool-based testing for all low-risk patients, helping to stratify who needs diagnostic colonoscopy versus ongoing noninvasive monitoring. Broader adoption of stool-based testing could reduce missed diagnoses, shorten time to treatment, and help close rural–urban screening gaps.

“With all patients receiving colonoscopy in our system, patients had an average wait time of 1 year from initial contact to colonoscopy,” wrote the researchers. “It is also more accessible for many patients and helps stratify low-risk individuals, identifying those who require diagnostic colonoscopy vs. those who can be adequately monitored with stool-based testing alone.”


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
ESR Analyzer
TEST1 2.0
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: Development of targeted therapeutics and diagnostics for extrapulmonary tuberculosis at University Hospital Cologne (Photo courtesy of Michael Wodak/Uniklinik Köln)

Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.